mRNA startup raises hundreds of thousands to check its focused most cancers therapies

When Jacob Becraft addressed a bustling social gathering of a hundred-plus workers, buddies, and traders at his startup’s lab final month, he credited messenger RNA for bringing everybody again collectively in a single room.

His remarks carried a double which means. Sure, the mRNA vaccines had allowed the big group to assemble in particular person — not a masks in sight. However Becraft’s Strand Therapeutics can also be one in all a number of Boston-area startups buoyed by the success of the COVID-19 photographs and hoping to increase the attain of mRNA medicines into most cancers and different illnesses.